Skip to content

Bumble, Inc. BMBL Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Other financials

Income statement

See full
Revenue$212.4M-14.1%
Gross profit$157.6M-9.3%
Operating income$65.3M+46.1%
Net income$45.2M+236%
EPS (diluted)$0.34+162%

Balance sheet

See full
Cash & equivalents$248.9M+21.0%
Total debt$597.3M-3.6%
Total equity$617.1M-24.2%
Total assets$1.5B-41.3%

Cash flow

See full
Operating cash flow$77.2M+78.6%

Valuation

See full
Market cap$383.47M-28.6%
Enterprise value$731.84M-23.0%
P/S0.4×-0.1×

Profitability

See full
Gross margin71.8%+1.3pp
Operating margin-84.3%+20.5pp
Net margin-71%+31.1pp

Returns & leverage

See full
Return on equity-92.4%+1,847pp
Debt / equity+0.2×
Current ratio1.2×-1.6×